Sarah Houlton, PhD, is Pharmaceutical Executive’s international correspondent.
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
Statins should be given to people with high blood pressure or diabetes, even if they don?t have heart disease, according to a study published in the British Medical Journal.
UK Health Institute leaves guidance unchanged in case against Eisai and Pfizer; more research on NICE methodology needed.
Diversity of ethnic groups and prevalence of Spanish language make Latin America an attractive destination for clinical trials.
It could be the end of the road for the UK's biotech firms if drastic action isn't taken soon.
EC proposal loosens restrictions on drug packaging and information dissemination.
The new EU directive looks to reduce, refine, and eventually replace animal testing
In Europe, it's different strokes for different folks at the top regulatory agencies
Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva